Logo
X

XenTech

30 employees

XenTech is an innovative biotech/CRO company specialized in the preclinical cancer drug efficacy evaluation and the identification.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
patient-derived tumor xenograft models
efficacy preclinical studies
PDX
oncology
Life Science
CDX
in vivo
biomarkers
Health Care
in-vitro assays

Date founded

2006

Funding rounds raised

Total raised

$765K

from 1 investors over 1 rounds

X

XenTech raised $765K on October 31, 2008

Investors: Aurinvest Capital 3

FAQ